Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation
The American Cancer Society estimates that in the current year, about 21,280 new cases of ovarian cancer will be diagnosed and 14,240 women will die of ovarian cancer in the USA.
